Jason Do
About Jason Do
Jason Do is an Associate Director of Clinical Operations at Sonoma Biotherapeutics, with extensive experience in clinical operations across various companies. He has held positions at Vical, SynteractHCR, Acadia Pharmaceuticals, and Arena Pharmaceuticals, and he holds a Bachelor of Science in Physiology and Neuroscience from UC San Diego.
Current Role at Sonoma BioTherapeutics
Jason Do serves as the Associate Director of Clinical Operations at Sonoma BioTherapeutics. He has held this position since 2021 and is based in the San Francisco Bay Area. In this role, he is responsible for overseeing clinical operations, ensuring that clinical trials are conducted efficiently and in compliance with regulatory standards.
Previous Experience in Clinical Operations
Before joining Sonoma BioTherapeutics, Jason Do accumulated extensive experience in clinical operations across various organizations. He worked at Acadia Pharmaceuticals Inc. as a Senior Clinical Study Manager from 2017 to 2021 and as a Clinical Study Manager from 2016 to 2017. Prior to that, he served as a Clinical Project Manager at Arena Pharmaceuticals from 2013 to 2016 and as a Manager of Clinical Operations at SynteractHCR from 2010 to 2013. His career began at Vical, where he worked as a Senior Clinical Research Associate and Project Lead from 2006 to 2010.
Educational Background in Physiology and Neuroscience
Jason Do earned a Bachelor of Science degree in Physiology and Neuroscience from the University of California, San Diego. His studies spanned from 1994 to 1999, providing him with a solid foundation in the biological sciences, which supports his work in clinical operations.
Career Timeline and Progression
Jason Do's career in clinical operations reflects a steady progression through various roles and responsibilities. He started as a Senior Clinical Research Associate at Vical, then advanced to managerial positions at SynteractHCR and Arena Pharmaceuticals. His roles at Acadia Pharmaceuticals further enhanced his expertise in clinical study management before he took on his current role at Sonoma BioTherapeutics.